Filing Details
- Accession Number:
- 0001209191-22-021546
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-29 20:54:35
- Reporting Period:
- 2022-03-25
- Accepted Time:
- 2022-03-29 20:54:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1493566 | Otonomy Inc. | OTIC | Pharmaceutical Preparations (2834) | 262590070 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1857476 | Charles Alan Foster | C/O Otonomy, Inc. 4796 Executive Drive San Diego CA 92121 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-03-25 | 1,827 | $2.39 | 179,576 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-03-28 | 2,559 | $2.41 | 177,017 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares were sold to cover tax obligations in connection with the vesting of Restricted Stock Units.
- This sale price represents the weighted average sale price of the shares sold ranging from $2.34 to $2.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Holder will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- This sale price represents the weighted average sale price of the shares sold ranging from $2.36 to $2.44 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Holder will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
